Related Experiment Videos
Steroid sparing effect of methotrexate in relapsing polychondritis
J Park1, K M Gowin, H R Schumacher
1University of Pennsylvania School of Medicine, Philadelphia, USA.
The Journal of Rheumatology
|May 1, 1996
Summary
Methotrexate can help manage relapsing polychondritis, a rare cartilage disorder. This steroid-sparing treatment proved effective for auricular chondritis in three patients.
Area of Science:
- Rheumatology
- Immunology
- Dermatology
Background:
- Relapsing polychondritis (RP) is a rare systemic inflammatory condition affecting cartilaginous tissues.
- RP management often involves corticosteroids, which can lead to significant side effects with long-term use.
- Tapering prednisone can exacerbate symptoms, posing a challenge in chronic RP treatment.
Observation:
- Three patients with biopsy-proven relapsing polychondritis were evaluated.
- These patients experienced auricular chondritis, a common and often debilitating manifestation of RP.
- Conventional treatment with prednisone was associated with symptom exacerbation during dose tapering.
Findings:
- Methotrexate was administered as a steroid-sparing agent in these RP patients.
- Significant improvement in auricular chondritis was observed with methotrexate therapy.
- The need for corticosteroids was reduced, indicating a steroid-sparing effect.
Implications:
- Methotrexate represents a viable therapeutic option for managing relapsing polychondritis, particularly auricular chondritis.
- This approach may reduce long-term corticosteroid toxicity in patients with RP.
- Further research into methotrexate's efficacy and safety in larger RP cohorts is warranted.